| 000 | 01378 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512005013.0 | ||
| 264 | 0 | _c19890809 | |
| 008 | 198908s 0 0 eng d | ||
| 022 | _a0014-2980 | ||
| 024 | 7 |
_a10.1002/eji.1830190517 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPlaetinck, G | |
| 245 | 0 | 0 |
_aInterleukin 1 and tumor necrosis factor enhance transcription from the SV40 early promoter in a T cell line. _h[electronic resource] |
| 260 |
_bEuropean journal of immunology _cMay 1989 |
||
| 300 |
_a897-904 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCycloheximide _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-1 _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aReceptors, Interleukin-2 _xbiosynthesis |
| 650 | 0 | 4 |
_aSimian virus 40 _xgenetics |
| 650 | 0 | 4 |
_aT-Lymphocytes _xphysiology |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 700 | 1 | _aCombe, M C | |
| 700 | 1 | _aCorthésy, P | |
| 700 | 1 | _aSeckinger, P | |
| 700 | 1 | _aNabholz, M | |
| 773 | 0 |
_tEuropean journal of immunology _gvol. 19 _gno. 5 _gp. 897-904 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/eji.1830190517 _zAvailable from publisher's website |
| 999 |
_c2550388 _d2550388 |
||